Clinical Trial Update: Anti-Inflammatory Reliever South Africa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in South Africa evaluating an anti-inflammatory reliever for asthma, currently recruiting. Sponsored by the University of KwaZulu-Natal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Anti-Inflammatory Reliever

Snippet

Sponsor: University of KwaZulu | Conditions: Asthma | Phase 3 | Status: RECRUITING